8th NovAliX Conference | Hybrid Event

Committee

Conference Chairman

Dr Jean-Paul RENAUD (Urania Therapeutics, Ostwald, France)

Scientific Committee

Members

Dr Chun-wa CHUNG (GlaxoSmithKline, Stevenage, United Kingdom)
Prof. Alessio CIULLI (University of Dundee, Dundee, United Kingdom)
Prof. Helena DANIELSON (Uppsala University, Uppsala, Sweden)
Dr Matthias FRECH (Merck, Darmstadt, Germany)
Dr Stefan GESCHWINDNER (AstraZeneca, Mölndal, Sweden)
Dr Sylwia HUBER (F. Hoffmann-La Roche, Basel, Switzerland)
Dr Sandra JACOB (Novartis Institutes for Biomedical Research, Basel, Switzerland)
Dr Herbert NAR (Boehringer Ingelheim, Biberach, Germany)
Dr Jean-Paul RENAUD (Urania Therapeutics, Ostwald, France)
Dr Stacey SOUTHALL (Sosei Heptares, Cambridge, United Kingdom)

Organised by

Premium Sponsor

Copyright 2022 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys